|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01640002 |
|
Date of registration:
|
11/07/2012 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
|
|
Scientific title:
|
A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder |
|
Date of first enrolment:
|
May 2012 |
|
Target sample size:
|
42 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01640002 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
|
|
Phase:
|
Phase 1
|
|
|
Countries of recruitment
|
|
Brazil
| | | | | | | |
|
Contacts
|
|
Name:
|
José Abraão Carneiro Neto |
|
Address:
|
|
|
Telephone:
|
557132838392 |
|
Email:
|
abraao.neto@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
Jose Abraão Carneiro Neto |
|
Address:
|
|
|
Telephone:
|
55+71+8149-1252 |
|
Email:
|
abraao.neto@gmail.com |
|
Affiliation:
|
|
|
|
Name:
|
José Abraão Carneiro Neto |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Service of Imunology - Universitary Hospital Prof. Edgard Santos |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- HTLV-1 infection
- More than 18 years
- Negative urine culture
- No neurological damage
Exclusion Criteria:
- Diabetes
- Persistently positive urine culture
- Pelvic, head, urological or gynecological surgery
- Stroke
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Overactive Bladder Associated With HTLV-1
|
|
Intervention(s)
|
|
Drug: Placebo
|
|
Drug: Propantheline Bromide
|
|
Primary Outcome(s)
|
|
Improve in Overactive bladder symptoms score
[Time Frame: 2 months]
|
|
Secondary Outcome(s)
|
|
Improvement in nocturia and urgency
[Time Frame: 2 months]
|
|
Secondary ID(s)
|
|
FR-473218
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|